Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model

Pharmaceutical Research

Volumn 20, Issue 3, 2003, Pages 417-422

  Pan, Xing Q ^a   Wang, Huaqing ^a   Lee, Robert J ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Doxorubicin; Drug targeting; Folate receptor; Liposomes; Xenograft

Indexed keywords

DOXORUBICIN; DOXORUBICIN LIPID COMPLEX; DRUG RECEPTOR; FOLIC ACID; LIPOSOME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CONTROLLED STUDY; DIET; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FOLIC ACID BLOOD LEVEL; HUMAN; HUMAN CELL; IN VIVO STUDY; LIFESPAN; MALE; MOUSE; MOUTH CARCINOMA; NONHUMAN; NUDE MOUSE; PHYSIOLOGY; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOLID TUMOR; SYSTEMIC CIRCULATION; TREATMENT OUTCOME; TUMOR CELL LINE; TUMOR GROWTH; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; DOXORUBICIN; FLUOROMETRY; FOLIC ACID; HUMANS; INJECTIONS, INTRAPERITONEAL; KB CELLS; LIPOSOMES; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MOUTH NEOPLASMS; NEOPLASM TRANSPLANTATION; RECEPTORS, CELL SURFACE; SURVIVAL ANALYSIS; TIME FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0037335188     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022656105022     Document Type: Article

References (26)

1. D. Goren, A. T. Horowitz, D. Tzemack, M. Tarshish, S. Zalipsky, and A. Gabizon. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Clin. Cancer Res. 6:1949-1957 (2000).
2. P. Garin-Chesa, I. Campbell, P. E. Saigo, J. L. Lewis Jr., L. J. Old, and W. J. Rettig. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. Am. J. Pathol. 142:557-567 (1993).
3. J. F. Ross, P. K. Chaudhuri, and M. Ratnam. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines - Physiologic and clinical implications. Cancer 73:2432-2443 (1994).
4. J. F. Ross, H. Wang, F. G. Behm, P. Mathew, M. Wu, R. Booth, and M. Ratnam. Folate receptor type β is neutrophilic lineage marker and is differentially expressed in myeloid leukemia. Cancer 85:348-357 (1999).
5. J. J. Sudimack and R. J. Lee. Targeted drug delivery via the folate receptor. Adv. Drug Deliv. Rev. 41:147-162 (2000).
6. J. A. Reddy and P. S. Low. Folate-mediated targeting of therapeutic and imaging agents to cancers. Crir. Rev. Ther. Drug Carrier Syst. 15:587-627 (1998).
7. R. J. Lee and P. S. Low. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol. Chem. 269:3198-3204 (1994).
8. W. Guo, T. Lee, J. J. Sudimack, and R. J. Lee. Receptor-specific delivery of liposomes via folate-PEG-chol. J. Liposome Res. 10:179-195 (2000).
9. A. Gabizon. Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy. Cancer Invest. 19:424-436 (2001).
10. R. J. Lee and P. S. Low. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim. Biophys. Acta 1233:134-144 (1995).
11. A. Gabizon, A. T. Horowitz, D. Goren, D. Tzemach, F. Madelbaum-Shavit, M. M. Qazen, and S. Zalipsky. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. Bioconjug. Chem. 10:289-298 (1999).
12. X. Q. Pan, X. Zheng, G. Shi, H. Wang, M. Ratnam, and R. J. Lee. Strategy for the treatment of acute myelogenous leukemia based on folate receptor β-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid. Blood 100:594-602 (2002).
13. X. Q. Pan, H. Wang, and R. J. Lee. Boron delivery to a murine lung carcinoma using folate receptor-targeted liposomes. Anticancer Res. 22:1629-1634 (2002).
14. M. J. Turk, D. J. Waters, G. Breur, W. R. Widmer, and P. S. Low. Folate-mediated targeting of liposomes to tumor cells and Mac-1 expressing cells in vivo. J. Control. Release 74:369-376 (2001).
15. J. C. Stewart. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal. Biochem. 104:10-14 (1980).
16. 99mTc-HYNIC-folate, a novel receptor-based targeted radiopharmaceutical for tumor imaging. J. Nucl. Med. 40:1563-1569 (1999).
17. J. Plowman, D. J. Dykes, M. Hollingshead, L. Simpson-Herren, and M. C. Alley. Human tumor xenograft models in NCI drug development. In B. Teicher (ed.). Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval, Humana Press, Totowa, New Jersey, 1997, pp. 101-125.
18. R. L. Hong, C. J. Huang, Y. L. Tseng, V. F. Pang, S. T. Chen, J. J. Liu, and F. H. Chang. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial? Clin. Cancer Res. 5:3645-3652 (1999).
19. J. Song, A. Medline, J. B. Mason, S. Gallinger, and Y.-I. Kim. Effects of dietary folate on intestinal tumorigenesis in the Apc Min mouse. Cancer Res. 60:5424-5440 (2000).
20. R. F. Branda, E. Nigels, A. R. Lafayette, and M. Hacker. Nutritional folate status influences the efficacy and toxicity of chemotherapy in rats. Blood 92:2471-2476 (1998).
21. J. M. Lawrence, D. B. Petitti, M. Watkins, and M. A. Umekubo. Trends in serum folate after food fortification. Lancet 354:915-916 (1999).
22. R. L. Walzem and A. J. Clifford. Folate deficiency in rats fed diets containing free amino acids or intact proteins. J. Nutr. 118:1089-1096 (1988).
23. R. K. Jain. Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. J. Control. Release 73:7-25 (2001).
24. J. W. Park, K. Hong, D. B. Kirpotin, D. Papahadjopoulos, and C. C. Benz. Immunoliposomes for cancer treatment. Adv. Pharmacol. 40:399-435 (1997).
25. T. Shinoda, A. Takagi, A. Maeda, S. Kagatani, Y. Konno, and M. Hashida. In vivo fate of folate-BSA in non-tumor- and tumor-bearing mice. J. Pharm. Sci. 87:1521-1526 (1998).
26. J. L.-S. Au, S. H. Jang, and M. G. Wientjes. Clinical aspects of drug delivery to tumors. J. Control. Release 78:81-95 (2002).